The MNTA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MNTA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The MNTA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View MNTA Detailed Price Forecast - CNN Money||View MNTA Detailed Summary - Google Finance|
|View MNTA Detailed Summary - Yahoo! Finance||View MNTA Stock Research & Analysis - Zacks.com|
|View MNTA Trends & Analysis - Trade-Ideas||View MNTA Major Holders - Barrons|
|View MNTA Call Transcripts - NASDAQ||View MNTA Breaking News & Analysis - Seeking Alpha|
|View MNTA Annual Report - CompanySpotlight.com||View MNTA OTC Short Report - OTCShortReport.com|
|View MNTA Fundamentals - TradeKing||View MNTA SEC Filings - Bar Chart|
|View Historical Prices for MNTA - The WSJ||View Performance/Total Return for MNTA - Morningstar|
|View the Analyst Estimates for MNTA - MarketWatch||View the Earnings History for MNTA - CNBC|
|View the MNTA Earnings - StockMarketWatch||View MNTA Buy or Sell Recommendations - MacroAxis|
|View the MNTA Bullish Patterns - American Bulls||View MNTA Short Pain Metrics - ShortPainBot.com|
|View MNTA Stock Mentions - StockTwits||View MNTA Stock Mentions - PennyStockTweets|
|View MNTA Stock Mentions - Twitter||View MNTA Investment Forum News - Investor Hub|
|View MNTA Stock Mentions - Yahoo! Message Board||View MNTA Stock Mentions - Seeking Alpha|
|View Insider Transactions for MNTA - SECform4.com||View Insider Transactions for MNTA - Insider Cow|
|View MNTA Major Holdings Summary - CNBC||View Insider Disclosure for MNTA - OTC Markets|
|View Insider Transactions for MNTA - Yahoo! Finance||View Institutional Holdings for MNTA - NASDAQ|
|View MNTA Stock Insight & Charts - FinViz.com||View MNTA Investment Charts - StockCharts.com|
|View MNTA Stock Overview & Charts - BarChart||View MNTA User Generated Charts - Trading View|
Free Stock Performance Review on Zoetis and Three Additional Generic Drugs Stocks
Posted on Tuesday June 19, 2018
LONDON, UK / ACCESSWIRE / June 19, 2018/ If you want a free Stock Review on ZTS sign up now at www.wallstequities.com/registration. Under evaluation this morning are these four stocks: Flexion Therapeutics Inc. (NASDAQ: FLXN), Momenta Pharmaceuticals Inc. (NASDAQ: MNTA), PetIQ Inc. (NASDAQ: PETQ), and Zoetis Inc. (NYSE: ZTS).
See what the IHS Markit Score report has to say about Momenta Pharmaceuticals Inc.
Posted on Friday June 08, 2018
Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on January 31. Index (PMI) data, output in the Healthcare sector is rising.
Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 39th Annual Global Healthcare Conference
Posted on Wednesday June 06, 2018
Momenta Pharmaceuticals, Inc. (MNTA), today announced that it will present at the Goldman Sachs 39th Annual Global Healthcare Conference. The presentation is scheduled for Wednesday, June 13, 2018 at 2:40 P.M. PT/5:40 P.M. ET. A webcast of the presentation will be available live on the “Investors” section of the company’s website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event. Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.
Should You Hold Momenta (MNTA) Stock in Your Portfolio?
Posted on Wednesday May 23, 2018
Momenta (MNTA) is conducting a strategic review of its ongoing operations as revenues from Glatopa continue to decline.